Serum interferon alpha receptor 2 mRNA may predict efficacy of interferon alpha with/without low-dose sorafenib for metastatic clear cell renal cell carcinomaNobutaka Furuya, Ken‐Ichiro Yoshida|Cancer Immunology Immunotherapy|2011Cited by 18